⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL316875 | 0.80 | CTSA (0.36) | — | |
| SCHEMBL11863035 | 0.78 | CTSA (0.35) | — | |
| Ammonia Solution, Strong SCHEMBL10803145 | 0.78 | CTSA (0.35) | — | |
| SCHEMBL11367484 | 0.78 | — | — | |
| SCHEMBL3065513 | 0.77 | CTSA (0.31) | — | |
| SCHEMBL28458546 | 0.77 | CTSA (0.31) | — | |
| SCHEMBL3501702 | 0.75 | — | — | |
| SCHEMBL10901012 | 0.75 | — | — | |
| SCHEMBL4650333 | 0.75 | — | — | |
| SCHEMBL19697585 | 0.75 | CTSA (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151408-A1 | COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION | DENALI THERAPEUTICS INC. (US) | 2025-07-17 | — | — | WO | claimed |
| CN-105307662-B | 4 '-fluoro-2' -methyl substituted nucleoside derivatives | 里博科学有限责任公司 | 2019-06-04 | — | — | CN | claimed |
| EP-3102215-A2 | 4'-DIFLUOROMETHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF INFLUENZA RNA REPLICATION | Riboscience LLC (US) | 2016-12-14 | — | — | EP | claimed |
| CN-105979951-A | 4' -difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication | 里博科学有限责任公司 | 2016-09-28 | — | — | CN | claimed |
| CN-105307662-A | 4 '-fluoro-2' -methyl substituted nucleoside derivatives | RIBOSCIENCE LLC | 2016-02-03 | — | — | CN | claimed |
| WO-2015120237-A2 | 4'-DIFLUOROMETHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF INFLUENZA RNA REPLICATION | RIBOSCIENCE LLC (US) | 2015-08-13 | — | — | WO | claimed |
| WO-2025151408-A1 | COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION | DENALI THERAPEUTICS INC. (US) | 2025-07-17 | — | — | WO | disclosed |
| US-11773126-B2 | Substituted nucleosides, nucleotides and analogs thereof | Janssen Pharmaceuticals, Inc. (US) | 2023-10-03 | — | — | US | disclosed |
| US-20230248749-A1 | INOSITOL PHOSPHATE COMPOUNDS FOR USE IN INCREASING TISSULAR PERFUSION | SANIFIT THERAPEUTICS, S.A. (ES) | 2023-08-10 | — | — | US | disclosed |
| US-20230201236-A1 | SPIROCYCLIC NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF HEPATITIS E | Janssen Pharmaceuticals, Inc. | 2023-06-29 | — | — | US | disclosed |
| US-20230201239-A1 | ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E | Janssen Pharmaceuticals, Inc. | 2023-06-29 | — | — | US | disclosed |
| US-20230167151-A1 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2023-06-01 | — | — | US | disclosed |
| US-20230159449-A1 | LIPID FORMULATIONS CONTAINING NUCLEIC ACIDS AND METHODS OF TREATMENT FOR CYSTIC FIBROSIS | ARCTURUS THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
| WO-2003060191-A2 | NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060192-A1 | NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060019-A1 | NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| EP-1139738-A1 | INSECTICIDAL SEED COATING | Syngenta Participations AG (CH) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000035277-A1 | INSECTICIDAL SEED COATING | SYNGENTA PARTICIPATIONS AG (CH) | 2000-06-22 | — | — | WO | disclosed |
| US-5876739-A | CORN SEEDS | NOVARTIS AG (CH) | 1999-03-02 | — | — | US | disclosed |
| WO-1996029337-A1 | THIONO TRIESTER MODIFIED ANTISENSE OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES | HYBRIDON, INC. (US) | 1996-09-26 | — | — | WO | disclosed |